-fovir
Antivirals carrying a phosphonate group, like tenofovir.
- Drugs ending in -fovir: 11
- Approved somewhere: 5
- With a US drug page: 4
- Stem
- -fovir
- Class
- Antivirals carrying a phosphonate group, like tenofovir
- Sub-stem of
- vir: Antivirals
- Most common targets
- P (5), POL (5), OPG071 (1), DNA polymerase catalytic subunit (1), REVERSE, TRANSCRIPTASE (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -fovir, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Adefovir dipivoxil | Approved | P | DNA polymerase/reverse transcriptase inhibitor |
| Brincidofovir | Approved | OPG071 | DNA polymerase inhibitor |
| Tenofovir alafenamide | Approved | POL | Human immunodeficiency virus type 1 reverse transcriptase inhibitor |
| Tenofovir disoproxil | Approved | POL, P | Human immunodeficiency virus type 1 reverse transcriptase inhibitor |
| Cidofovir anhydrous | Approved | DNA polymerase catalytic subunit | Human herpesvirus 1 DNA polymerase inhibitor |
| Adefovir | Phase 3 | P | DNA polymerase/reverse transcriptase inhibitor |
| Besifovir | Phase 3 | — | — |
| Pradefovir | Phase 3 | P | DNA polymerase/reverse transcriptase inhibitor |
| Tenofovir anhydrous | Phase 3 | POL, P | Human immunodeficiency virus type 1 reverse transcriptase inhibitor |
| Rovafovir etalafenamide | Phase 2 | POL | Human immunodeficiency virus type 1 reverse transcriptase inhibitor |
| Tenofovir exalidex | Phase 2 | POL, REVERSE, TRANSCRIPTASE | Human immunodeficiency virus type 1 reverse transcriptase inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO